Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 24, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | $52.67B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ONC | BEONE MEDICINES LTD | $34.60B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FIX | COMFORT SYSTEMS USA INC | $34.05B | 0.20% | 7.20% | $0.6000 | $1.95 | 3% | 0 | ||
| NVT | NVENT ELECTRIC PLC | $16.78B | 0.58% | 21.80% | $0.2000 | $0.60 | 12% | 0 | 2026-01-23 | 2026-02-06 |
| NBIX | NEUROCRINE BIOSCIENCES INC | $14.68B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VTRS | VIATRIS INC | $13.84B | 3.99% | -15.50% | $0.1200 | $0.48 | 77% | 0 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $10.30B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SGHC | SUPER GROUP (SGHC) LTD | $6.05B | 0.33% | 46.20% | $0.0400 | $0.04 | 5% | 0 | ||
| GTES | GATES INDUSTRIAL CORP PLC | $5.73B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPA | COPA HOLDINGS SA | $5.02B | N/A | 33.20% | $1.6100 | N/A | N/A | 1 | ||
| UGP | ULTRAPAR HOLDINGS INC | $4.03B | 2.08% | 33.10% | $0.0774 | $0.08 | 47% | 6 | ||
| CALX | CALIX INC | $3.67B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SPNT | SIRIUSPOINT LTD | $2.62B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HCI | HCI GROUP INC | $2.54B | 0.82% | 9.30% | $0.4000 | $1.60 | 19% | 0 | ||
| EXTR | EXTREME NETWORKS INC | $2.24B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ANIP | ANI PHARMACEUTICALS INC | $1.81B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BLBD | BLUE BIRD CORP | $1.65B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.59B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DNOW | DNOW INC | $1.43B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ANAB | ANAPTYSBIO INC | $1.39B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | $1.23B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TBLA | TABOOLACOM LTD | $1.20B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NUTX | NUTEX HEALTH INC | $1.18B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CRTO | CRITEO SA | $1.07B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TBPH | THERAVANCE BIOPHARMA INC | $940.99M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ORGO | ORGANOGENESIS HOLDINGS INC | $729.74M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | $515.71M | 4.39% | N/A | $0.2850 | $0.61 | 80% | 2 | ||
| VREX | VAREX IMAGING CORP | $502.90M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LE | LANDS' END INC | $434.44M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EGHT | 8X8 INC | $273.12M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| OPRX | OPTIMIZERX CORP | $237.48M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| ELMD | ELECTROMED INC | $228.11M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LTRX | LANTRONIX INC | $226.31M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CXDO | CREXENDO INC | $202.82M | N/A | 0.00% | $0.0050 | N/A | N/A | 0 | ||
| INFU | INFUSYSTEM HOLDINGS INC | $183.84M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.